Central Retinal Artery Occlusion: A Retinal Emergency

What Is Central Retinal Artery Occlusion?

What Is Central Retinal Artery Occlusion?

CRAO belongs to a group of conditions called retinal vascular diseases, which involve problems with the blood vessels that supply the retina. Understanding what happens during a CRAO helps explain why acting fast is so critical.

The retina is the thin, light-sensitive layer of tissue at the back of the eye that converts light into signals the brain interprets as vision. The central retinal artery is the primary blood vessel that delivers oxygen and nutrients to this tissue. The retina has one of the highest metabolic demands of any tissue in the body, meaning it requires a constant, uninterrupted blood supply to function.

When the central retinal artery becomes blocked, blood flow to the retina stops or is severely reduced. Without oxygen, retinal cells begin to fail within minutes, a process called ischemia. If blood flow is not restored quickly, the damage becomes permanent. The severity of vision loss depends largely on how long the blockage lasts and whether any alternative blood supply exists within the affected eye.

CRAO shares the same underlying disease processes as stroke and heart attack. A blockage in the retinal artery reflects the same vascular conditions that can simultaneously threaten blood vessels in the brain. This is why a CRAO event triggers stroke-level urgency and why patients are typically referred to a stroke center as part of their initial evaluation, alongside specialized eye care.

Who Is Affected and Why

Who Is Affected and Why

CRAO most often affects people in their 60s, and men are affected somewhat more frequently than women. Understanding who is most at risk helps with prevention and early recognition.

CRAO is a relatively uncommon condition, with an estimated incidence of approximately 1.9 cases per 100,000 people per year when adjusted for age and sex. While the overall numbers are low, the consequences for vision and cardiovascular health can be severe. Because CRAO is closely linked to heart and vascular disease, it tends to occur in the same populations affected by stroke and heart attack.

The risk factors for CRAO are nearly identical to those for stroke and heart disease. The most important modifiable risk factors include:

  • Cigarette smoking
  • High blood pressure (hypertension)
  • High cholesterol and elevated blood lipid levels
  • Diabetes
  • Elevated body weight
  • Heart disease, particularly atrial fibrillation (an irregular heart rhythm)

Controlling these risk factors is one of the most effective ways to reduce the risk of a retinal vascular event and other serious cardiovascular conditions.

Atrial fibrillation is a heart rhythm disorder in which the heart beats irregularly, which can allow blood clots to form inside the heart chambers. These clots can then travel through the bloodstream and block arteries in the eye, brain, or elsewhere in the body. Research has found that close to half of all CRAO patients are discovered to have previously undiagnosed atrial fibrillation following their eye event. This means a sudden loss of vision may be the first visible sign of a heart condition that had not yet been detected.

Certain blood disorders and inflammatory conditions also raise the risk of CRAO. These include polycythemia vera (a condition in which the body produces too many red blood cells), sickle cell anemia, multiple myeloma, and inherited clotting disorders such as factor V Leiden mutation. Elevated homocysteine levels in the blood, inflammatory vascular diseases such as Behcet disease, and rare conditions like moyamoya disease and Fabry disease may also contribute in some patients.

Symptoms of CRAO

The symptoms of CRAO are distinctive and demand immediate action. Recognizing them, even in their earliest or mildest form, can directly affect whether any treatment options remain available.

The defining symptom of CRAO is a sudden, severe loss of vision in one eye that occurs without any pain. The vision loss typically develops over seconds and is often profound. Research indicates that approximately 80 percent of people with CRAO are left with only counting fingers vision or worse in the affected eye. Vision at this level means a person can detect motion or count fingers held close to their face, but cannot read, drive, or perform most visually demanding tasks. This statistic underscores why acting within the first minutes of symptom onset is so critical.

Some people experience brief episodes of temporary vision loss in one eye before a full CRAO occurs. This is called amaurosis fugax, a painless, fleeting loss of vision that typically resolves on its own within seconds to a few minutes. Although vision returns to normal, this is not a reassuring symptom to observe and wait on. Amaurosis fugax can be a direct warning that a full retinal artery occlusion or stroke may be imminent. Anyone who experiences even one episode of temporary vision loss in one eye should seek emergency evaluation the same day, without waiting to see whether it happens again.

When a retina specialist examines an eye affected by CRAO, several characteristic findings are visible. The retina appears pale and whitened because it is not receiving adequate blood flow. At the center of the retina, in an area called the macula (which is responsible for sharp, detailed vision), a bright red spot known as a cherry-red spot is typically present. This occurs because the central retinal tissue is thin enough that the blood-rich layer beneath shows through, while the surrounding swollen retina appears white by contrast.

A retina specialist will also test for an afferent pupillary defect, sometimes called a Marcus Gunn pupil. This is when the pupil of the affected eye does not react normally to light, indicating significant disruption to the visual pathway from the retina to the brain.

How CRAO Is Diagnosed

Diagnosis is often possible quickly because the clinical picture is distinctive. However, a thorough evaluation is still necessary to confirm the diagnosis, assess the extent of retinal damage, and identify the underlying cause.

A retina specialist can typically diagnose CRAO based on the history of sudden, painless vision loss combined with the characteristic appearance of the retina. The examination includes careful inspection of the retina, measurement of visual acuity, and testing of pupil responses. The pale retina with a cherry-red spot at the macula is a hallmark finding that strongly supports the diagnosis.

Optical coherence tomography (OCT) is a non-invasive imaging test that creates detailed cross-sectional images of the retinal layers. In CRAO, OCT may show swelling and thickening in the inner retinal layers, consistent with ischemic injury. Fluorescein angiography uses a special dye injected into a vein to photograph blood flow in the retina. It may reveal delayed or absent filling of the blocked artery and helps characterize the extent of the occlusion.

Because CRAO and stroke share the same underlying mechanisms, current medical guidelines recommend that patients with an acute CRAO be referred promptly to a stroke center for evaluation. Carotid artery imaging checks for plaque buildup in the large neck arteries that supply blood to the eye and brain. Cardiac testing, including an electrocardiogram (to check heart rhythm) and an echocardiogram (an ultrasound of the heart), is standard. Blood tests assess cholesterol, blood sugar, clotting factors, and inflammatory markers. Brain imaging may also be performed to rule out a concurrent or recent stroke. This comprehensive workup identifies treatable conditions that can help prevent future, potentially life-threatening events.

Treatment Options for CRAO

Treatment Options for CRAO

CRAO is a medical emergency, and treatment decisions must be made as quickly as possible. While there is currently no treatment proven to reliably restore vision in all patients, acting fast preserves options and may improve outcomes for some individuals.

Research using experimental models suggests that retinal tissue can tolerate a complete loss of blood flow for approximately 90 minutes without permanent damage. Partial recovery may still be possible if flow is restored within about four hours. Once a blockage has persisted beyond approximately four hours, the likelihood of significant, irreversible retinal damage increases substantially. This narrow window is why CRAO demands the same urgency as a stroke, and why emergency evaluation must not be delayed under any circumstances.

The American Heart Association has recommended considering intravenous thrombolysis for appropriate patients with acute CRAO. Thrombolysis is a medication delivered through a vein that works to dissolve the clot causing the blockage. This treatment is only considered within 4.5 hours of symptom onset and only in patients who have no medical conditions that would make it unsafe. Available research suggests potential benefit for some patients treated within this window, though the evidence continues to develop and not all patients are candidates. Thrombolysis is administered in a hospital emergency setting, not in an outpatient office.

Over the years, several other treatments have been attempted for CRAO. These include ocular massage (pressing rhythmically on the eye to try to dislodge the blockage), medications to lower eye pressure, and breathing techniques intended to dilate blood vessels. Current medical evidence does not support these approaches as reliably effective. Delivering clot-dissolving medication directly into the blocked artery through a catheter has also been studied but is not currently supported by sufficient evidence for routine use.

Even when restoring vision is not possible, treating the underlying cardiovascular condition is essential and can be life-saving. Managing high blood pressure, high cholesterol, diabetes, and atrial fibrillation reduces the risk of stroke and heart attack. It also reduces the risk of a similar event occurring in the other eye. This aspect of CRAO care is just as important as any intervention directed at the eye itself, and it requires close collaboration between your retina specialist, primary care physician, and cardiologist.

Visual Outcomes and Recovery

Outcomes after CRAO vary significantly from person to person. Understanding the factors that influence recovery helps patients and families set realistic expectations and plan for the future.

The overall visual prognosis after CRAO is serious. Research indicates that approximately 80 percent of people with CRAO are left with only counting fingers vision or worse in the affected eye. The unaffected eye typically continues to function normally, which allows most people to maintain a meaningful level of independence and the ability to manage daily activities. However, the loss of vision in one eye can significantly affect depth perception and peripheral awareness, which is why ongoing follow-up and support are important.

There is an important exception to the generally poor visual prognosis of CRAO. Approximately 25 percent of people have an additional small artery, called a cilioretinal artery, that supplies a portion of the central retina. Unlike the central retinal artery, this vessel has a separate origin, so it may continue to nourish the central macula even when the main artery is completely blocked. Patients with a functional cilioretinal artery have significantly better outcomes. Research shows that more than 80 percent of these patients recover to 20/50 vision or better, a level that supports reading and many daily activities. A retina specialist can determine whether this artery is present during examination and imaging.

After a CRAO, regular follow-up is necessary for two important reasons. First, a retina specialist will monitor the affected eye for complications such as neovascularization, which is the abnormal growth of fragile new blood vessels that can develop as a result of prolonged retinal ischemia and may require treatment if it occurs. Second, ongoing management of the cardiovascular conditions identified during the initial workup is essential for long-term health. Blood pressure, cholesterol, and blood sugar should be actively monitored and treated over time.

Living Well After CRAO

Recovery from CRAO involves more than managing the eye itself. Long-term wellbeing depends on addressing overall vascular health, protecting the unaffected eye, and adapting to any lasting vision changes.

Working closely with your medical team to address the cardiovascular conditions that contributed to the CRAO is one of the most important steps in long-term care. Quitting smoking, controlling blood pressure, managing cholesterol, treating diabetes, and maintaining a healthy weight all reduce the risk of future vascular events, including stroke and heart attack. If atrial fibrillation has been diagnosed, following a cardiologist's treatment plan, which may include blood-thinning medication, is essential for preventing future clots.

After a CRAO in one eye, protecting the health of the other eye becomes a priority. Because the underlying vascular disease affects the entire cardiovascular system, the other eye is not without long-term risk. Regular retinal examinations allow for early detection of any developing changes. Managing the conditions that caused the first event is the most effective protection not only for the remaining eye, but also for the heart and brain.

If significant vision loss has occurred in one eye, our retina specialists can connect you with resources to help make the most of remaining vision. Low-vision rehabilitation services may include magnifying devices, specialized lighting, and practical techniques for adapting to daily activities. It is completely natural to feel anxious, frustrated, or overwhelmed after an experience like CRAO. Speaking openly with your care team about these feelings is encouraged, and connecting with a vision loss support group can provide both practical guidance and meaningful emotional support.

When to Seek Emergency Care

When to Seek Emergency Care

Knowing when and how to act in response to vision symptoms can directly affect whether any options for treatment remain. CRAO is one of the few conditions in eye care where minutes genuinely determine whether tissue survives.

If you experience sudden, painless vision loss in one eye, go to the nearest emergency room or call emergency services immediately. Do not wait to see if vision improves on its own. Do not call your eye doctor's office and wait for a callback. Every minute without blood flow to the retina increases the likelihood of permanent damage, and the window for any available treatment is extremely narrow. Prompt emergency evaluation is the only way to preserve any possibility of intervention.

Even if vision loss in one eye lasts only seconds and resolves completely, this symptom requires same-day urgent evaluation. Temporary vision loss, known as amaurosis fugax, can be a warning sign that a full retinal artery occlusion or stroke may be imminent. If you experience any sudden change in vision in one eye, a curtain or shadow across your vision, or a brief blackout of vision in one eye, seek emergency care right away. Do not wait to see whether the symptom recurs before acting.

Frequently Asked Questions

Here are answers to questions we commonly hear from patients and families after a CRAO diagnosis or a recent vision scare.

CRAO is often described as a stroke of the eye because it involves the same type of arterial blockage, occurring in the retinal artery rather than a brain artery. From a practical care standpoint, this comparison matters: in the emergency room, the evaluation and urgency level for CRAO mirrors that of a cerebral stroke. Importantly, a CRAO also signals an elevated risk that a stroke in the brain could occur, which is why brain imaging and a full stroke-level workup are typically completed on the same day, at a stroke center, rather than scheduled as separate future appointments.

Whether vision can be recovered depends on how quickly care is sought, what treatments are safely available, and whether a cilioretinal artery is present in the affected eye. If you arrive at an emergency room within the treatment window and are a candidate for intravenous thrombolysis, that may influence outcomes in some cases. If significant time has already passed, the focus typically shifts to monitoring for complications and protecting long-term eye and cardiovascular health. Regardless of when you are reading this, the best next step is evaluation by a retina specialist as soon as possible so that your individual situation can be fully assessed.

Beyond the eye examination and retinal imaging, expect a comprehensive medical workup targeting the cardiovascular system. This typically includes ultrasound imaging of the carotid arteries in your neck, an electrocardiogram to check heart rhythm, an echocardiogram (a heart ultrasound) to look for structural problems or clot sources, and blood tests checking cholesterol, blood sugar, clotting function, and inflammatory markers. Brain imaging such as an MRI may also be performed if you are evaluated at a stroke center. This workup frequently identifies treatable conditions that, left unaddressed, could lead to a far more serious event such as a stroke or heart attack.

It is uncommon for both eyes to be affected at the same time. Simultaneous bilateral CRAO is rare and, when it does occur, typically signals a severe underlying systemic cause that requires immediate evaluation. However, because the underlying vascular disease affects the entire body, the unaffected eye is not without long-term risk. The most effective protection for the remaining eye is consistent management of blood pressure, cholesterol, diabetes, and other contributing conditions, combined with regular follow-up retinal examinations to detect any early changes before they progress.

Do not ignore even a single episode of temporary vision loss in one eye, even if vision returned to normal within seconds. Go to the emergency room or contact your retina specialist the same day it occurs. This symptom, called amaurosis fugax, can be a direct warning sign of an impending retinal artery occlusion or stroke. Early evaluation gives your care team the opportunity to identify the underlying cause and begin treatment that may help prevent a much more serious event. The fact that vision came back on its own does not mean the risk has passed.

Expert Retina Care Across Connecticut

At New England Retina Associates, our fellowship-trained retina specialists have extensive experience diagnosing and managing retinal vascular emergencies, including central retinal artery occlusion. We work closely with emergency medicine teams, cardiologists, and neurologists throughout Connecticut to ensure that every patient receives coordinated, expert care from the moment of concern through long-term follow-up. If you have been referred following a retinal vascular event, or if you have concerns about your vision or vascular health, we are here to help guide you through every step of the process.

30 Years of Care & Commitment

Google Reviews